Immunopathogenic mechanisms in psoriasis

Area of Science:

• Immunodermatology
• Autoimmune skin diseases
• T cell immunology

Background:

• Psoriasis is a common autoimmune skin disease with a complex genetic basis.
• The HLA-Cw*0602 allele is a major susceptibility factor, influencing clinical features and disease risk.
• CD8+ T cells are implicated as key effector cells in psoriasis pathogenesis.

Purpose of the Study:

• To elucidate the roles of CD4+ and CD8+ T cells in psoriasis.
• To investigate the interaction between T cells and antigen-presenting cells in the context of HLA-Cw*0602.
• To understand the mechanisms underlying disease fluctuations and remissions.

Main Methods:

• Analysis of T cell populations (CD4+ and CD8+) in psoriatic lesions.
• Investigation of T cell interactions with keratinocytes and dendritic cells.
• Exploration of the role of HLA-Cw*0602 in antigen presentation and T cell activation.

Main Results:

• CD4+ T cells are crucial for initiating and sustaining psoriasis.
• Cross-primed CD8+ T cells act as primary effector cells, responding to antigens presented by HLA-Cw*0602 on keratinocytes.
• A complex interplay involving CD4+, CD8+ T cells, and cross-presenting dendritic cells influences Th1 polarization and disease activity.

Conclusions:

• CD8+ T cells are the main effector cells in psoriasis, particularly in individuals with the HLA-Cw*0602 allele.
• The balance between effector and suppressor T cells may regulate disease activity and spontaneous remissions.
• Understanding these T cell dynamics offers potential therapeutic targets for psoriasis management.